PPIL6

gene
On this page

Also known as bA425D10.6MGC41939dJ919F19.1RSPH12

Summary

PPIL6 (peptidylprolyl isomerase like 6, HGNC:21557) is a protein-coding gene on chromosome 6q21, encoding Probable inactive peptidyl-prolyl cis-trans isomerase-like 6 (Q8IXY8). Probable inactive PPIase with no peptidyl-prolyl cis-trans isomerase activity.

Predicted to enable RNA polymerase II CTD heptapeptide repeat P3 isomerase activity and RNA polymerase II CTD heptapeptide repeat P6 isomerase activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be active in cytoplasm.

Source: NCBI Gene 285755 — RefSeq curated summary.

At a glance

  • GWAS associations: 7
  • Clinical variants (ClinVar): 68 total
  • MANE Select transcript: NM_173672

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:21557
Approved symbolPPIL6
Namepeptidylprolyl isomerase like 6
Location6q21
Locus typegene with protein product
StatusApproved
AliasesbA425D10.6, MGC41939, dJ919F19.1, RSPH12
Ensembl geneENSG00000185250
Ensembl biotypeprotein_coding
Entrez285755

Gene structure

Transcript identifiers

Ensembl transcripts: 14 — 12 protein_coding, 1 nonsense_mediated_decay, 1 protein_coding_CDS_not_defined

ENST00000417394, ENST00000424445, ENST00000440797, ENST00000447468, ENST00000518648, ENST00000520723, ENST00000521072, ENST00000524031, ENST00000897716, ENST00000897717, ENST00000897718, ENST00000961131, ENST00000961132, ENST00000961133

RefSeq mRNA: 4 — MANE Select: NM_173672 NM_001111298, NM_001286360, NM_001286361, NM_173672

CCDS: CCDS47466, CCDS5074, CCDS69169

Canonical transcript exons

ENST00000521072 — 8 exons

ExonStartEnd
ENSE00001296630109431157109431345
ENSE00001306599109436104109436199
ENSE00003490339109426847109426994
ENSE00003558647109419187109419243
ENSE00003573693109427094109427156
ENSE00003655910109400035109400170
ENSE00003701651109390215109392937
ENSE00003896640109440456109440628

Expression profiles

Bgee: expression breadth ubiquitous, 173 present calls, max score 93.78.

FANTOM5 (CAGE): breadth ubiquitous, TPM avg 2.7093 / max 52.7769, expressed in 1038 samples.

FANTOM5 promoters (3 alternative TSS)

Promoter IDTPM avgSamples expressed
749962.56231013
749970.080532
749980.066637

Top tissues by expression

251 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
right uterine tubeUBERON:000130293.78gold quality
olfactory segment of nasal mucosaUBERON:000538692.67gold quality
spermCL:000001988.15silver quality
right testisUBERON:000453488.02gold quality
mucosa of paranasal sinusUBERON:000503088.02silver quality
left testisUBERON:000453387.83gold quality
calcaneal tendonUBERON:000370186.39gold quality
testisUBERON:000047385.18gold quality
cortical plateUBERON:000534384.40gold quality
ventricular zoneUBERON:000305384.32gold quality
bronchial epithelial cellCL:000232883.17gold quality
epithelium of bronchusUBERON:000203182.89gold quality
bronchusUBERON:000218581.83gold quality
male germ line stem cell (sensu Vertebrata) in testisCL:0000089 ∩ UBERON:000047381.13gold quality
primordial germ cell in gonadCL:0000670 ∩ UBERON:000099179.50gold quality
epithelium of nasopharynxUBERON:000195178.79silver quality
islet of LangerhansUBERON:000000678.37gold quality
ganglionic eminenceUBERON:000402377.18gold quality
fallopian tubeUBERON:000388977.01gold quality
left lobe of thyroid glandUBERON:000112076.98gold quality
thyroid glandUBERON:000204676.59gold quality
nucleus accumbensUBERON:000188275.33gold quality
caudate nucleusUBERON:000187375.26gold quality
right lobe of thyroid glandUBERON:000111975.25gold quality
tendonUBERON:000004374.65gold quality
hindlimb stylopod muscleUBERON:000425273.93gold quality
prefrontal cortexUBERON:000045173.68gold quality
left ovaryUBERON:000211973.68gold quality
Brodmann (1909) area 9UBERON:001354073.49gold quality
pancreasUBERON:000126473.27gold quality

Single-cell (SCXA)

Detected in 4 experiment(s), a significant marker in 3.

ExperimentMarker?Max mean expression
E-MTAB-10287yes26.19
E-ANND-3yes8.49
E-MTAB-9388yes7.40
E-ENAD-17no88.05

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

82 targeting PPIL6, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-4795-3P100.0074.624024
HSA-MIR-1252-5P100.0069.802774
HSA-MIR-3613-3P100.0076.367965
HSA-MIR-126-5P100.0072.713180
HSA-MIR-371B-5P99.9975.344759
HSA-MIR-1213699.9872.815713
HSA-MIR-373-5P99.9875.364753
HSA-MIR-616-5P99.9875.584775
HSA-MIR-499A-5P99.9870.791323
HSA-MIR-27A-3P99.9872.132955
HSA-MIR-27B-3P99.9872.132955
HSA-MIR-998599.9872.112939
HSA-MIR-520D-5P99.9873.344883
HSA-MIR-524-5P99.9873.434882
HSA-MIR-480399.9871.993117
HSA-MIR-60799.9773.625593
HSA-MIR-146A-5P99.9668.93988
HSA-MIR-146B-5P99.9669.13977
HSA-MIR-211099.9666.681930
HSA-MIR-6780B-5P99.9669.602562
HSA-MIR-7153-5P99.9468.891006
HSA-MIR-10523-5P99.9169.222038
HSA-MIR-548E-5P99.8972.734486
HSA-MIR-4728-5P99.8569.394718
HSA-MIR-6785-5P99.8268.684428
HSA-MIR-3121-3P99.8271.963630
HSA-MIR-4760-5P99.8069.881619
HSA-MIR-320A-3P99.7769.732107
HSA-MIR-320B99.7769.732107
HSA-MIR-320C99.7769.732107

Cross-species orthologs

5 orthologs

OrganismSymbolGene ID
danio_rerioppil6ENSDARG00000042157
mus_musculusPpil6ENSMUSG00000078451
rattus_norvegicusPpil6ENSRNOG00000043186
drosophila_melanogasterCyp40FBGN0036020
caenorhabditis_elegansWBGENE00000885

Paralogs (22): PPIE (ENSG00000084072), PPIL2 (ENSG00000100023), PPIF (ENSG00000108179), PPWD1 (ENSG00000113593), NKTR (ENSG00000114857), PPIL4 (ENSG00000131013), PPIL1 (ENSG00000137168), PPIG (ENSG00000138398), CWC27 (ENSG00000153015), PPIB (ENSG00000166794), PPIC (ENSG00000168938), PPID (ENSG00000171497), PPIH (ENSG00000171960), PPIA (ENSG00000196262), PPIAL4G (ENSG00000236334), PPIL3 (ENSG00000240344), PPIAL4A (ENSG00000263353), PPIAL4H (ENSG00000270339), PPIAL4E (ENSG00000271567), PPIAL4F (ENSG00000279782), PPIAL4C (ENSG00000288867), PPIAL4D (ENSG00000289549)

Protein

Protein identifiers

Probable inactive peptidyl-prolyl cis-trans isomerase-like 6Q8IXY8 (reviewed: Q8IXY8)

Alternative names: Cyclophilin-like protein PPIL6, Rotamase PPIL6

All UniProt accessions (5): B4DEK6, Q8IXY8, H0Y7C3, H0YAQ8, H0YC62

UniProt curated annotations — full annotation on UniProt →

Function. Probable inactive PPIase with no peptidyl-prolyl cis-trans isomerase activity.

Similarity. Belongs to the cyclophilin-type PPIase family.

Isoforms (3)

UniProt IDNamesCanonical?
Q8IXY8-11yes
Q8IXY8-22
Q8IXY8-33

RefSeq proteins (4): NP_001104768, NP_001273289, NP_001273290, NP_775943* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR002130Cyclophilin-type_PPIase_domDomain
IPR029000Cyclophilin-like_dom_sfHomologous_superfamily

Pfam: PF00160

UniProt features (5 total): splice variant 2, chain 1, domain 1, sequence variant 1

Structure

Experimental structures (PDB)

1 structures.

PDBMethodResolution (Å)
8J07ELECTRON MICROSCOPY4.1

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q8IXY8-F192.390.86

Function

Pathways and Gene Ontology

Reactome pathways

1 pathways

IDPathway
R-HSA-9918481Dengue Virus-Host Interactions

MSigDB gene sets: 65 (showing top): SENGUPTA_NASOPHARYNGEAL_CARCINOMA_DN, MARIADASON_RESPONSE_TO_BUTYRATE_CURCUMIN_SULINDAC_TSA_8, RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN, GOMF_CIS_TRANS_ISOMERASE_ACTIVITY, DODD_NASOPHARYNGEAL_CARCINOMA_DN, GOMF_ISOMERASE_ACTIVITY, LU_EZH2_TARGETS_UP, FIGUEROA_AML_METHYLATION_CLUSTER_6_UP, REACTOME_INFECTIOUS_DISEASE, FOXD2_TARGET_GENES, FOXJ2_TARGET_GENES, HAND1_TARGET_GENES, NFKBIA_TARGET_GENES, SNIP1_TARGET_GENES, ZIM3_TARGET_GENES

GO Biological Process (1): protein peptidyl-prolyl isomerization (GO:0000413)

GO Molecular Function (3): peptidyl-prolyl cis-trans isomerase activity (GO:0003755), protein binding (GO:0005515), isomerase activity (GO:0016853)

GO Cellular Component (1): cytoplasm (GO:0005737)

Reactome top-level categories

Rollup of top-1 pathways:

CategoryPathways
Dengue Virus Infection1

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
peptidyl-proline modification1
cis-trans isomerase activity1
catalytic activity, acting on a protein1
binding1
catalytic activity1
intracellular anatomical structure1
cellular anatomical structure1

Protein interactions and networks

STRING

1634 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
PPIL6SYF2O95926532
PPIL6ZBTB24O43167474
PPIL6RSPH3Q86UC2464
PPIL6ATAD5Q96QE3449
PPIL6RSPH14Q9UHP6430
PPIL6SLC67A2Q8NBP5400
PPIL6MTRES1Q9P0P8377
PPIL6PPIL4Q8WUA2369
PPIL6CFAP300Q9BRQ4367
PPIL6DNAJC27Q9NZQ0357
PPIL6LSAMPQ13449341
PPIL6RFC4P35249339
PPIL6EYA4O95677339
PPIL6RSPH9Q9H1X1330
PPIL6CHURC1Q8WUH1330

IntAct

13 interactions, top by confidence:

ABTypeScore
SORBS3PPIL6psi-mi:“MI:0915”(physical association)0.560
PPIL6APPBP2psi-mi:“MI:0915”(physical association)0.560
BAG4PPIL6psi-mi:“MI:0915”(physical association)0.560
BIVMPPIL6psi-mi:“MI:0915”(physical association)0.560
PPIL6SORBS3psi-mi:“MI:0915”(physical association)0.000
PPIL6BAG4psi-mi:“MI:0915”(physical association)0.000
PPIL6APPBP2psi-mi:“MI:0915”(physical association)0.000
PPIL6BIVMpsi-mi:“MI:0915”(physical association)0.000

BioGRID (7): PPIL6 (Affinity Capture-MS), PPIL6 (Synthetic Lethality), PPIL6 (Two-hybrid), PPIL6 (Two-hybrid), PPIL6 (Two-hybrid), PPIL6 (Two-hybrid), PPIL6 (Cross-Linking-MS (XL-MS))

ESM2 similar proteins: A0AVT1, A0JMM9, A2RVS4, A3KMX8, A3KNL6, A6H630, A8MRP2, D2TN58, O74834, P0AE48, P0AE49, P0AE50, P0AE51, P35875, P38074, P41888, P54121, P87305, Q16P90, Q32LH7, Q4H4F0, Q4R526, Q58EM4, Q5SPB6, Q66I06, Q66KX0, Q6AXB1, Q6DJA3, Q6INN8, Q7L1T6, Q7TS68, Q84QC1, Q8GY54, Q8IU29, Q8IXY8, Q8RX87, Q8TEA1, Q9C5X8, Q9FIX1, Q9FIX2

Diamond homologs: A0A0R0H9T5, A2AR02, A8X8D0, B3A0R0, D4AY02, H2QII6, O43447, O49605, O49886, O55035, O93826, O94273, P0C1H7, P0C1I1, P0C1I3, P0C1I7, P0C1I8, P0C1I9, P0CP78, P0CP79, P14088, P14832, P18253, P21568, P21569, P22011, P23285, P24525, P25007, P25719, P26882, P30404, P30412, P30414, P30415, P34790, P35176, P35627, P45877, P48820

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

68 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance56
Likely benign4
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

1672 predictions. Top by Δscore:

VariantEffectΔscore
6:109400168:CAT:Cacceptor_gain1.0000
6:109400170:TC:Tacceptor_loss1.0000
6:109400171:C:Aacceptor_loss1.0000
6:109400171:C:CCacceptor_gain1.0000
6:109400172:T:Gacceptor_loss1.0000
6:109419182:CATA:Cdonor_loss1.0000
6:109419183:ATAC:Adonor_loss1.0000
6:109419184:TA:Tdonor_loss1.0000
6:109419185:ACC:Adonor_loss1.0000
6:109419186:C:CAdonor_loss1.0000
6:109429731:C:Adonor_gain1.0000
6:109431179:G:Cdonor_gain1.0000
6:109436102:AC:Adonor_gain1.0000
6:109436103:CC:Cdonor_gain1.0000
6:109436208:C:CTacceptor_gain1.0000
6:109441168:GCTG:Gdonor_gain1.0000
6:109400029:ACAT:Adonor_loss0.9900
6:109400030:CAT:Cdonor_loss0.9900
6:109400031:ATA:Adonor_loss0.9900
6:109400032:TA:Tdonor_loss0.9900
6:109400033:A:ACdonor_gain0.9900
6:109400033:A:AGdonor_loss0.9900
6:109400033:AC:Adonor_gain0.9900
6:109400034:C:CCdonor_gain0.9900
6:109400034:C:CGdonor_loss0.9900
6:109400034:CC:Cdonor_gain0.9900
6:109400166:TTCAT:Tacceptor_gain0.9900
6:109400167:TCAT:Tacceptor_gain0.9900
6:109400168:CATC:Cacceptor_gain0.9900
6:109400169:AT:Aacceptor_gain0.9900

AlphaMissense

2054 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
6:109426879:C:GR200P0.994
6:109440503:C:AG30W0.988
6:109400035:C:TG275E0.987
6:109436133:A:GW68R0.987
6:109436133:A:TW68R0.987
6:109400036:C:AG275W0.986
6:109400131:A:TL243H0.986
6:109400037:A:CF274L0.985
6:109400037:A:TF274L0.985
6:109400039:A:GF274L0.985
6:109426957:A:GF174S0.984
6:109431263:A:GL105P0.984
6:109436195:A:GL47P0.984
6:109400041:G:TA273D0.983
6:109400088:G:CF257L0.983
6:109400088:G:TF257L0.983
6:109400090:A:GF257L0.983
6:109426862:A:GW206R0.983
6:109426862:A:TW206R0.983
6:109426956:A:CF174L0.983
6:109426956:A:TF174L0.983
6:109426958:A:GF174L0.983
6:109440502:C:TG30E0.983
6:109400089:A:GF257S0.982
6:109440460:G:TA44D0.982
6:109426959:A:CN173K0.981
6:109426959:A:TN173K0.981
6:109440461:C:GA44P0.981
6:109440503:C:GG30R0.980
6:109440503:C:TG30R0.980

dbSNP variants (sampled 300 via entrez): RS1000056939 (6:109437362 G>A,T), RS1000218907 (6:109398829 A>G), RS1000232437 (6:109419387 C>G,T), RS1000299142 (6:109435703 T>A), RS1000315803 (6:109433070 T>C), RS1000415180 (6:109400868 T>G), RS1000559993 (6:109420893 T>A), RS1000595802 (6:109427559 G>C,T), RS1000652146 (6:109434570 C>T), RS1000664085 (6:109425767 A>G), RS1000727337 (6:109422158 G>T), RS1000786246 (6:109407249 T>C), RS1000901178 (6:109434573 T>C), RS1000923525 (6:109406936 A>G), RS1000982062 (6:109440564 G>A,C,T)

Disease associations

OMIM: gene `` | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

7 associations (top):

StudyTraitp-value
GCST000175_27Height4.000000e-06
GCST002647_58Height2.000000e-17
GCST90002385_566High light scatter reticulocyte count5.000000e-18
GCST90002386_108High light scatter reticulocyte percentage of red cells5.000000e-11
GCST90002388_2Lymphocyte count5.000000e-10
GCST90002389_333Lymphocyte percentage of white cells6.000000e-13
GCST90002399_304Neutrophil percentage of white cells2.000000e-12

EFO canonical traits (4, from GWAS)

EFO IDTrait name
EFO:0007986reticulocyte count
EFO:0004587lymphocyte count
EFO:0007993lymphocyte percentage of leukocytes
EFO:0007990neutrophil percentage of leukocytes

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

30 total (human), top 30 by PubMed support.

ChemicalActions (top 5)PubMed papers
Valproic Aciddecreases expression, increases methylation, affects cotreatment3
bisphenol Adecreases expression, decreases methylation, increases methylation2
Air Pollutantsincreases abundance, increases expression2
Smokedecreases expression, increases abundance, increases expression2
Tretinoindecreases expression2
Particulate Matterincreases abundance, increases expression2
trichostatin Aaffects expression1
tris(1,3-dichloro-2-propyl)phosphateincreases expression1
sodium arsenitedecreases expression1
perfluorooctanoic acidincreases expression1
CGP 52608affects binding, increases reaction1
perfluoro-n-nonanoic acidincreases expression1
4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamidedecreases expression, affects cotreatment1
ICG 001increases expression1
abrinedecreases expression1
dorsomorphinaffects cotreatment, decreases expression1
MT19c compoundincreases expression1
Rosiglitazoneincreases expression1
Acetaminophenincreases expression1
Benzo(a)pyreneincreases expression1
Diethylhexyl Phthalatedecreases expression1
Estradiolincreases expression1
Niclosamideincreases expression1
Phenobarbitalincreases expression1
Rotenoneincreases expression1
Dihydrotestosteroneincreases expression1
Tetrachlorodibenzodioxinincreases expression1
Tobacco Smoke Pollutiondecreases expression1
Cyclosporineincreases expression1
Cadmium Chloridedecreases expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.